Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance-Reference-Cited by-同舟云学术

Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance

Published:2022-02 Issue:2 Volume:4 Page:100409
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Johnson Katherine,Leary Peter J.^ORCID,Govaere Olivier^ORCID,Barter Matthew J.,Charlton Sarah H.,Cockell Simon J.,Tiniakos Dina^ORCID,Zatorska Michalina,Bedossa Pierre,Brosnan M. Julia,Cobbold Jeremy F.^ORCID,Ekstedt Mattias^ORCID,Aithal Guruprasad P.^ORCID,Clément Karine,Schattenberg Jörn M.,Boursier Jerome,Ratziu Vlad,Bugianesi Elisabetta,Anstee Quentin M.^ORCID,Daly Ann K.,Clark James,Cordell Heather J.,Darlay Rebecca,Day Christopher P.,Hardy Tim,Liu Yang-Lin,Oakley Fiona,Palmer Jeremy,Queen Rachel,Wonders Kristy,Bossuyt Patrick M.,Holleboom Adriaan G.,Zafarmand Hadi,Vali Yasaman,Lee Jenny,Clement Karine,Pais Raluca,Schuppan Detlef,Allison Michael,Cuenca Sergio Rodriguez,Pellegrinelli Vanessa,Vacca Michele,Vidal-Puig Antonio,Hyötyläinen Tuulia,McGlinchey Aidan,Orešič Matej,Sen Partho,Mato Jose,Millet Óscar,Dufour Jean-Francois,Harrison Stephen,Neubauer Stefan,Pavlides Michael,Mozes Ferenc,Akhtar Salma,Banerjee Rajarshi,Kelly Matt,Shumbayawonda Elizabeth,Dennis Andrea,Erpicum Charlotte,Romero-Gomez Manuel,Gallego-Durán Rocío,Fernández Isabel,Karsdal Morten,Leeming Diana,Fisker Mette Juul,Erhardtsen Elisabeth,Rasmussen Daniel,Qvist Per,Sinisi Antonia,Sandt Estelle,Tonini Maria Manuela,Parola Maurizio,Rosso Chiara,Marra Fabio,Gastaldelli Amalia,Francque Sven,Kechagias Stergios,Yki-Järvinen Hannele,Porthan Kimmo,van Mil Saskia,Papatheodoridis George,Cortez-Pinto Helena,Valenti Luca,Petta Salvatore,Miele Luca,Geier Andreas,Trautwein Christian,Hockings Paul,Newsome Phil,Wenn David,Pereira Rodrigues Cecília Maria,Hanf Rémy,Chaumat Pierre,Rosenquist Christian,Trylesinski Aldo,Ortiz Pablo,Duffin Kevin,Yunis Carla,Miller Melissa,Tuthill Theresa,Ertle Judith,Younes Ramy,Alexander Leigh,Ostroff Rachel,Kjær Mette Skalshøi,Mikkelsen Lars Friis,Brass Clifford,Jennings Lori,Balp Maria-Magdalena,Martic Miljen,Hanauer Guido,Shankar Sudha,Torstenson Richard,Fournier Céline,Ehman Richard,Kalutkiewicz Michael,Pepin Kay,Myers Joel,Shevell Diane,Ho Gideon,Landgren Henrik,Myers Rob,Doward Lynda,Whalley Diane,Twiss James

Funder

IMI

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference50 articles.

1. Non-alcoholic fatty liver disease – a global public health perspective;Younossi;J Hepatol,2019

2. The genetics of NAFLD;Anstee;Nat Rev Gastroenterol Hepatol,2013

3. From NASH to HCC: current concepts and future challenges;Anstee;Nat Rev Gastroenterol Hepatol,2019

4. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort;Anstee;J Hepatol,2020

5. Genetic factors that affect risk of alcoholic and nonalcoholic fatty liver disease;Anstee;Gastroenterology,2016

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circular RNA RRM2 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miR-142-5p to increase NRG1 expression;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-10-01

2. Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases;Journal of Hepatology;2024-08

3. The role of hsa‐miR‐193a‐5p as an important factor for control of inositol in alopecia areata;Skin Research and Technology;2024-06-25

4. Plasma Extracellular MicroRNAs Associated With Cardiovascular Disease Risk Factors in Middle‐Aged and Older Adults;Journal of the American Heart Association;2024-06-18

5. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity;World Journal of Gastroenterology;2024-01-28